Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis

(2020) Daisuke Waki et al.   MEDICINE

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

(2020) Michael Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterizing infection in anti-neutrophil cytoplasmic antibody–associated vasculitis: results from a longitudinal, matched-cohort data linkage study

(2020) Shifa H Sarica et al.   RHEUMATOLOGY

Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Renal Disease

(2020) Marta Casal Moura et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

ANCA-associated vasculitis

(2020) A. Richard Kitching et al.   Nature Reviews Disease Primers

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study

(2019) Dimitrios Chanouzas et al.   BMC Nephrology

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis

(2019) Ruth J Pepper et al.   RHEUMATOLOGY

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

(2018) Stephen P McAdoo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Development and validation of a renal risk score in ANCA-associated glomerulonephritis

(2018) Silke R. Brix et al.   KIDNEY INTERNATIONAL

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Intravenous Cyclophosphamide and Plasmapheresis in Dialysis-Dependent ANCA-Associated Vasculitis

(2012) R. J. Pepper et al.   Clinical Journal of the American Society of Nephrology

Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study

(2012) M. Hilhorst et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Histopathologic Classification of ANCA-Associated Glomerulonephritis

(2010) A. E. Berden et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES